RxDoctor Payments DataLook up a doctor →

Michael Chaglasian, OD

Optometrist · Chicago, ILNPI 1841283330

Payments from drug & device makers

$682,690in general payments, 2019–2025

Across 568 payments — averaging $1201.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Topcon Healthcare, Inc.$420K
  • Bausch & Lomb Americas Inc.$63K
  • AbbVie$38K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$30K
  • Thea Pharma Inc.$24K
  • Carl Zeiss Meditec, Inc.$22K
  • plus $85K from 24 others
$2,500in research payments, 2019–2025

Across 1 payment — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch & Lomb Americas Inc.$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$682,690 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$17,930
Medicare patients
68
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →